Metraipolis › archive › dc_0705f0fbb9c8

TREM-1 inhibitor specificity and timing of treatment initiation can impact its therapeutic efficacy in cancer and inflammatory disease — Europe PMC PMID:41404075

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41404075
DOI
10.3389/fonc.2025.1689771
License (as archived)
solo-consultazione
Archived
2026-11-08T02:40:40.147Z
SHA-256 of the archived text
d95acc82db2140174d1559a459b2a9ab48611ff84c1ce70b3cb49a2e77b3ce8d
Stable URL of this page
https://metraipolis.com/documento/dc_0705f0fbb9c8

How to cite

TREM-1 inhibitor specificity and timing of treatment initiation can impact its therapeutic efficacy in cancer and inflammatory disease — Europe PMC PMID:41404075 — Europe PMC (en), https://europepmc.org/article/MED/41404075 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0705f0fbb9c8 (Metraipolis archive dc_0705f0fbb9c8, sha256 d95acc82db2140174d1559a459b2a9ab48611ff84c1ce70b3cb49a2e77b3ce8d)
BibTeX
@misc{dc0705f0fbb9c8,
  title = {TREM-1 inhibitor specificity and timing of treatment initiation can impact its therapeutic efficacy in cancer and inflammatory disease — Europe PMC PMID:41404075},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41404075},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0705f0fbb9c8; sha256 d95acc82db2140174d1559a459b2a9ab48611ff84c1ce70b3cb49a2e77b3ce8d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41404075. Agents can read the archived copy with the MCP tool read_document.